BenjaminCCreelanMD

Health and Culture

Physician

Overview of Dr. Creelan

Dr. Benjamin Creelan is an internist in Philadelphia, PA and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Sidney Kimmel Medical College and has been in practice 10 years. Dr. Creelan accepts several types of health insurance, listed below. He is one of 61 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Internal Medicine.

Office
111 S 11th St
Philadelphia, PA 19107
Book by Phone+1(813) 590-4346
Is this information wrong?

Education & Training

University of South Florida Morsani College of MedicineFellowship, Hematology/Oncology, 2010 - 2013
Thomas Jefferson UniversityResidency, Internal Medicine, 2007 - 2010
Sidney Kimmel Medical CollegeClass of 2007

Certifications & Licensure

FL State Medical License 2009 - 2022
PA State Medical License 2007 - 2010
American Board of Internal Medicine Internal Medicine

Clinical Trials

An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Start of enrollment: 2014 Mar 01Chachoua, A.,Creelan, B.,Chao, B.,Reynolds, C.,Gerber, D.E.,Morris, D.G.,Quddus, F.,Badin, F.,Blumenschein, G.,Borghaei, H.,Chaft, J.,Mccracken, J.,Wagner, K.,Horn, L.,Foley, M.,Socinski, M.,Leighl, N.,Re...
MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC) Start of enrollment: 2014 Mar 01Creelan, B.,Gibbons, D.,Kim, D.,Creelan, D.B.,Gibbons, D.D.,Chow, D.L.,Chow, L.,Kim, S.
RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) Start of enrollment: 2013 Dec 01Creelan, B.,Gibney, G.T.,Luke, J.
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC Alberto A Chiappori, MD

Publications & Presentations

PubMed

Selpercatinib Overcomes CCDC6-RET-Mediated Resistance to Osimertinib.
Misty D. Shields, J. Kevin Hicks, Theresa A. Boyle, Eric B. Haura, Benjamin C. Creelan> ;Journal of Thoracic Oncology. 2021 Mar 1
3 citations
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
Benjamin C. Creelan, Tammie C. Yeh, Sang We Kim, Naoyuki Nogami, Dong-Wan Kim, Laura Quan Man Chow, Shintaro Kanda, Rosemary Taylor, Weifeng Tang, Mei Tang, Helen K. A...> ;British Journal of Cancer. 2021 Jan 19
A community-based lung cancer rapid tissue donation protocol provides high-quality drug-resistant specimens for proteogenomic analyses.
Theresa A. Boyle, Gwendolyn P. Quinn, Matthew B. Schabath, Teresita Muñoz-Antonia, James Saller, Luisa F. Duarte, Laura S. Hair, Jamie K. Teer, Derek Y. Chiang, Rebecc...> ;Cancer Medicine. 2020 Jan 1
1 citations
Clinical Activity of Nivolumab for Human Papilloma Virus‐Related Juvenile‐Onset Recurrent Respiratory Papillomatosis
Ben C. Creelan, M. Usman Ahmad, Frank J. Kaszuba, Farah Khalil, Allison Welsh, Metin Ozdemirli, Nazaneen N. Grant, Deepa Subramaniam> ;Oncologist. 2019 Jun 1
12 citations
The NKG2A immune checkpoint - a new direction in cancer immunotherapy.
Benjamin C. Creelan, Scott Antonia> ;Nature Reviews Clinical Oncology. 2019 May 1
12 citations
Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer
Alexa B. Schrock, Allison Welsh, Jon Chung, Dean Pavlick, Eric H. Bernicker, Benjamin C. Creelan, Brady Forcier, Jeffrey S. Ross, Philip J. Stephens, Siraj M. Ali, Ibi...> ;Journal of Thoracic Oncology. 2019 Feb 1
4 citations
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC
Michael E. Goldberg, Meagan Montesion, Lauren Young, James Suh, Joel R. Greenbowe, Mark Kennedy, Giuseppe Giaccone, Wallace Akerley, Afshin Dowlati, Benjamin C. Creela...> ;PLOS ONE. 2018 Nov 27
32 citations
Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors.
Alexa B. Schrock, Viola W. Zhu, Wen-Son Hsieh, Russell Madison, Benjamin Creelan, Jeffrey Silberberg, Dan Costin, Anjali Bharne, Ioana Bonta, Thangavijayan Bosemani, P...> ;Journal of Thoracic Oncology. 2018 Sep 1
1 citations
Clinical Activity of Crizotinib in Lung Adenocarcinoma Harboring a Rare ZCCHC8-ROS1 Fusion
J. Kevin Hicks, Theresa A. Boyle, Lee A. Albacker, Russell Madison, Garrett M. Frampton, Benjamin C. Creelan> ;Journal of Thoracic Oncology. 2018 Aug 1
275 citations
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
Matthew D. Hellmann, Tavi Nathanson, Hira Rizvi, Benjamin C. Creelan, Francisco Sanchez-Vega, Arun Ahuja, Ai Ni, Jacki B. Novik, Levi Mangarin, Mohsen Abu-Akeel, Caili...> ;Cancer Cell. 2018 May 14
3 citations
Patient, caregiver and physician perspectives on participating in a thoracic rapid tissue donation program.
Gwendolyn P. Quinn, Rebecca D. Pentz, Teresita Muñoz-Antonia, Theresa A. Boyle, Matthew B. Schabath, Christie Pratt, Andrea Shaffer, Luisa F. Duarte, Meghan Bowman-Cur...> ;Patient Education and Counseling. 2017 Nov 28
6 citations
MET-GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors.
Matthew A. Smith, Thomas Licata, Aliya Lakhani, Marileila Varella Garcia, Hans Ulrich Schildhaus, Vincent Vuaroqueaux, Balazs Halmos, Alain C. Borczuk, Y. Ann Chen, Be...> ;Clinical Cancer Research. 2017 Nov 15
831 citations
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
David P. Carbone, Martin Reck, Luis Paz-Ares, Benjamin C. Creelan, Leora Horn, Martin Steins, Enriqueta Felip, Michel M. van den Heuvel, Tudor-Eliade Ciuleanu, Firas B...> ;The New England Journal of Medicine. 2017 Jun 21
1 citations
The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
Tawee Tanvetyanon, Benjamin C. Creelan, Scott J. Antonia> ;Expert Review of Anticancer Therapy. 2016 Aug 22
7 citations
Propelling Immunotherapy Combinations Into the Clinic.
Nishan Tchekmedyian, Jhanelle E. Gray, Benjamin C. Creelan, Alberto Chiappori, Amer A. Beg, Hatem Soliman, Bradford A. Perez, Scott J. Antonia> ;Oncology. 2015 Dec 16
5 citations
Current clinical application of genomic and proteomic profiling in non-small-cell lung cancer.
Tawee Tanvetyanon, Benjamin C. Creelan, Alberto Chiappori> ;Cancer Control. 2014 Jan 1
56 citations
Update on immune checkpoint inhibitors in lung cancer.
Benjamin C. Creelan> ;Cancer Control. 2014 Jan 1
2 citations
A fatal case of alemtuzumab-associated interstitial pneumonitis.
Benjamin Creelan, Andrés Ferber> ;American Journal of Therapeutics. 2008 Jan 1
Join now to see all

Lectures

Landscape of kinase rearrangements (kRE) detected in circulating tumor DNA (ctDNA).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Hospital Affiliations

H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida

Insurance Accepted

Aetna Choice POS II
Aetna HMO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment